INTRODUCTION
============

Cyclophosphamide (CP), an oxazaphosphorine alkylating agent, is widely used in the treatment of various human malignancies ([@b20-bt-23-180]). However, hemorrhagic cystitis (HC) is a major potential toxicity and dose-limiting side effect of CP, which has been a main problem for physicians during chemotherapy.

Although the exact mechanism of CP-induced HC is still not fully understood, chemical-induced oxidative stress is believed to be a major contributing factor to its HC probably related to differential metabolism of CP into acrolein ([@b3-bt-23-180]; [@b25-bt-23-180]; [@b47-bt-23-180]). Reactive oxygen species (ROS) trigger the activation of critical signaling molecules and then initiate signaling transduction ([@b40-bt-23-180]). Furthermore, ROS can activate multiple signaling pathways that influence the cytotoxicity observed in affected cells, including nuclear transcription factor kappa-B (NF-κB) and the phosphorylation cascades leading to the activation of mitogen-activated protein kinases (MAPKs), thus modulating a number of different steps in the inflammatory cascade ([@b23-bt-23-180]). MAPKs and NF-κB have important activities as mediators of cellular responses to extracellular signals, and are thought to play an important role in the regulation of proinflammatory molecules on cellular responses ([@b23-bt-23-180]; [@b42-bt-23-180]).

MAPKs, which include extracellular signal regulated kinase (ERK), c-jun N-terminal kinase (JNK), and p38 subfamilies, are important regulatory proteins through which various extracellular signals are transduced into intracellular responses. They regulate inflammatory proteins as well as immune responses and expression of various cytokines, e.g., interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) ([@b17-bt-23-180]). Previous studies demonstrated that CP-induced HC leads to ERK activation in urinary bladder ([@b9-bt-23-180]). Evidences confirmed that activation of JNK and p38 MAPKs may be involved in the mechanism of CP-induced HC ([@b42-bt-23-180]).

NF-κB belongs to the Rel family of transcriptional activator proteins, which has a critical role mediating inflammation, apoptosis, and growth in inflammatory disease. Modulation of NF-κB modifies the expression of genes involved in the inflammatory process, including inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and proinflammatory cytokines ([@b10-bt-23-180]). A previous study also reported that NF-κB is the prime molecular targets for the chemoprevention and cytoprotection with anti-inflammatory and antioxidant phytochemicals ([@b44-bt-23-180]). Recently, it has been also shown that NF-κB and MAPKs have an important role in the pathogenesis of CP-induced HC in rats ([@b25-bt-23-180]; [@b47-bt-23-180]; [@b42-bt-23-180]).

Garlic oil contains more than 20 organosulfur compounds, which can be considered as a dietary anticancer component. Among these compounds, diallyl disulfide (DADS), a major component of the secondary metabolites derived from garlic, has been well documented as a potent compound in prevention of cancer, genotoxicity, nephrotoxicity, urotoxicity, and hepatotoxicity ([@b34-bt-23-180]; [@b13-bt-23-180]; [@b38-bt-23-180]; [@b12-bt-23-180]; [@b24-bt-23-180]; [@b30-bt-23-180]). Accroding to our previous studies, DADS treatment results in increased antioxidant capacity and induction of antioxidant enzyme activities such as scavenging of ROS ([@b24-bt-23-180]; [@b30-bt-23-180]). Previous *in vitro* studies have also shown that DADS as a potential inhibitor revealed anti-inflammatory effect by down-regulation of NF-κB and MAPKs signaling pathways ([@b37-bt-23-180]; [@b48-bt-23-180]). Furthermore, previous studies indicate that suppression of MAPKs and inactivation of NF-κB may be a useful therapy for attenuating the inflammatory responses ([@b26-bt-23-180]; [@b50-bt-23-180]; [@b6-bt-23-180]).

DADS has been confirmed to have a protective effect against CP-induced urotoxicity and oxidative stress ([@b31-bt-23-180]). Recently, we have demonstrated that the protective effects of DADS against CP-induced bladder toxicity possibly involve mechanisms related to its ability to induce antioxidant activity and antiapoptotic effect by activating Nrf-2-antioxidant response element pathway and block metabolic activation of CP by inhibiting CYP2C11 and inducing CYP3A1 ([@b24-bt-23-180]). However, the role of DADS influencing NF-κB and MAPKs to regulate proinflammatory cytokines during urotoxicity is obscure. The present study investigated the protective effects of DADS against CP-induced HC in male rats. In order to better understand the protection mechanism of DADS, potential effects of DADS on serum proinflammatory cytokines, protein expression of NF-κB, iNOS, COX-2, TNF-α, and MAPKs, oxidative damage, and urinary nitrite-nitrate (NOx), malondialdehyde (MDA), and 8-hydroxy-2'-deoxyguanosine (8-OHdG) were also assessed.

MATERIALS AND METHODS
=====================

Animals and environmental conditions
------------------------------------

Male Sprague-Dawley rats aged 12 weeks were obtained from a specific pathogen-free colony at Samtako Co. (Osan, Republic of Korea) and used after one week of quarantine and acclimation. Two animals per cage were housed in a room maintained at a temperature of 23 ± 3°C and a relative humidity of 50 ± 10% with artificial lighting from 08:00 to 20:00 and with 13 to 18 air changes per hour. Commercial rodent chow (Samyang Feed, Wonju, Republic of Korea) sterilized by radiation and sterilized tap water were available *ad libitum*. The Institutional Animal Care and Use Committee of Chonnam National University approved the protocols for the animal study, and the animals were cared for in accordance with the Guidelines for Animal Experiments of Chonnam National University.

Test chemicals and treatment
----------------------------

CP was purchased from Sigma Aldrich Co. (St. Louis, MO, USA). DADS was purchased from Tokyo Kasei Chemical Co. (Tokyo, Japan). All other chemicals were of the highest grade commercially available. CP and DADS were dissolved in saline and corn oil, respectively, and were prepared immediately before treatment. The daily application volumes of CP (2 ml/kg body weight) and DADS (5 ml/kg body weight) were calculated in advance based on the most recently recorded body weight of the individual animal. DADS was gavaged to rats once daily for a period of 5 days at 100 mg/kg/day. One hour after the final DADS treatment, the rats were given a single intraperitoneal dose of CP (100 mg/kg/day). All of the animals were sacrificed 12 h after administration of CP.

Experimental groups and dose selection
--------------------------------------

A total of 24 healthy male rats were randomly assigned to four experimental groups as follows: (1) vehicle control, (2) CP, (3) CP&DADS, and (4) DADS (n = 6 per group). The dose of CP and DADS was based on earlier studies ([@b24-bt-23-180]; [@b30-bt-23-180]).

NO metabolites, 8-OHdG, and MDA in urine
----------------------------------------

Urine samples were collected in metabolic cages for 2 h just before killing and frozen at −80°C until analysis. MDA and NOx levels in urine were measured by an enzyme-linked immunosorbent assay (ELISA) kit (Cayman, Ann Arbor, MI, USA) according to manufacturer's instructions. NOx and MDA levels were expressed as micromoles. Urinary 8-OHdG levels were determined by a sandwich ELISA kit (Cayman). The concentration of creatinine in the urine samples was determined using a creatinine kit purchased from Cayman chemicals. Data were shown as the ratio of 8-OHdG to creatinine ([@b19-bt-23-180]).

Necropsy and tissue preparation
-------------------------------

After 12 h of HC induction, all male rats were euthanized by carbon dioxide inhalation for blood sample collection. Serum samples were collected by centrifugation at 1,600×g for 10 min and stored in the −80°C freezer before they were analyzed. After bleeding, the urinary bladders were removed. The bladders were cut into two equal pieces from dome to bottom. Half of the bladder was fixed for 24 h in 10% buffered form-aldehyde for histopathological evaluation while the remainder was stored at −80°C to measure bladder oxidative damage and Western blot analysis.

Cytokines assay
---------------

Highly specific quantitative sandwich ELISA kits for IL-1β, IL-6, and TNF-α were purchased from Thermo Fisher Scientific (Rockford, IL, USA).

Histopathological examination
-----------------------------

The bladders were routinely processed, embedded in paraffin and sectioned at 4-μm thickness, deparaffinized, and rehydrated using standard techniques. The sections were stained with hematoxylin-eosin stain for microscopic examination. All sections were examined with a light microscope by a pathologist blinded to the sample treatments.

Determination of lipid peroxidation (LPO), glutathione (GSH), and antioxidant enzymes
-------------------------------------------------------------------------------------

The weighed frozen bladder was homogenized in a glass-Teflon homogenizer with 50 mM phosphate buffer (pH 7.4) to obtain 1:9 (w/v) whole homogenate. The homogenates were then centrifuged at 11,000×*g* for 15 min at 4°C to discard any cell debris, and the supernatant was used for the measurement of MDA, reduced GSH concentrations and activities of glutathione reductase (GR) and glutathione-S-transferase (GST). The concentration of MDA was assayed by monitoring thiobarbituric acid reactive substance formation by the method of [@b2-bt-23-180]. GSH content was measured by the method of [@b33-bt-23-180]. The activities of antioxidant enzymes including GST ([@b14-bt-23-180]), and GR ([@b5-bt-23-180]) were also determined according to previously documented procedures. Total protein concentrations were determined by Bradford's method (1976), using bovine serum albumin as the standard.

Western blot analysis
---------------------

The frozen bladder tissues were lysed with a RIPA lysis buffer (Cell Signaling Technology, Lexington, KY, USA), and were centrifuged at 12,000×*g* at 4°C for 10 min to obtain the cellular proteins in the supernatant. The supernatant of bladder tissues separated by SDS-PAGE and transferred to a polyvinylidene difluoride membrane (Millipore, Bedford, MA, USA), and blocked in blocking buffer (150 mM NaCl in 10 mM Tris, pH 7.5 containing 5% non-fat dry milk) for 1 h at room temperature. The membranes were incubated with primary antibodies for 18 h at 4°C, washed three times (20 mM Tris-HCl, pH 7.5, 137 mM NaCl, and 0.1% Tween 20), incubated with horse-radish peroxidase-conjugated secondary antibodies (1:5,000, Thermo Fisher Scientific) for 1 h at room temperature, washed three times, and then detected with enhanced chemiluminescence method (Supersignal West Pico, Pierce, USA). Antibodies against β-actin, NF-κB, iNOS, COX-2, TNF-α, ERK 1/2, p-ERK 1/2, p38, p-p38, JNK, and p-JNK (1:1,000) were purchased from Abcam (Cambridge, MA, USA) and Cell Signaling Technology. The protein concentration was determined by BCA Protein Assay Kit (Pierce, Rockford, IL, USA).

Statistical analyses
--------------------

The results are expressed as mean ± SD, and all statistical comparisons were made by means of one-way analysis of variance (ANOVA) followed by Tukey's multiple comparison test. Differences with a *p*-value of 0.05 or lower were considered to be statistically significant.

RESULTS
=======

Effects of DADS on bladder histopathology
-----------------------------------------

The results of histopathological examination are shown in [Fig. 1](#f1-bt-23-180){ref-type="fig"}. The control and DADS groups presented bladders with normal architecture ([Fig. 1A, D](#f1-bt-23-180){ref-type="fig"}). In the CP group, however, bladder tissues showed inflammatory cells infiltration and epithelial ulceration ([Fig. 1B](#f1-bt-23-180){ref-type="fig"}). Although these findings were also observed in the CP&DADS group ([Fig. 1C](#f1-bt-23-180){ref-type="fig"}), the incidence and severity of histopathological lesions decreased compared with those in the CP group.

Effects of DADS on serum cytokines
----------------------------------

The results of the serum cytokines are presented in [Fig. 2](#f2-bt-23-180){ref-type="fig"}. The levels of IL-1β, IL-6, and TNF-α in the CP group increased significantly compared with those in the control group. In contrast, the levels of IL-1β and IL-6 in the CP&DADS group decreased significantly compared with those in the CP group. The TNF-α level in the CP&DADS group was also slightly lower than that in the CP group but the difference was not significant.

Effects of DADS on urinary NO metabolites, 8-OHdG, and MDA levels
-----------------------------------------------------------------

[Fig. 3A](#f3-bt-23-180){ref-type="fig"} shows the effects of DADS on CP-induced changes in urinary NOx levels. The CP treatment caused a significant increase in the urinary NOx level when compared with that in the control group. In contrast, the urinary NOx level in the CP&DADS group decreased significantly compared with that in the CP group. To evaluate the extent of oxidative stress in the rats, urinary MDA ([Fig. 3B](#f3-bt-23-180){ref-type="fig"}), a sensitive indicator of LPO, and urinary 8-OHdG ([Fig. 3C](#f3-bt-23-180){ref-type="fig"}), a sensitive indicator of oxidative DNA damage, were determined. The CP treatment caused significant increase in the urinary MDA and 8-OHdG levels when compared with those in the control group. Although no significant differences were observed between the groups, the urinary MDA and 8-OHdG levels in the CP&DADS group were lower than those in the CP group.

Effects of DADS on oxidative damage in urinary bladder
------------------------------------------------------

The MDA and GSH concentrations and the antioxidant enzymes activities in bladder tissues are presented in [Fig. 4](#f4-bt-23-180){ref-type="fig"}. The concentration of MDA increased significantly and GSH content and GR and GST activities decreased significantly in the CP group when compared with those in the control group. In contrast, the concentration of MDA in the CP&DADS group decreased significantly compared with that in the CP group, whereas the GSH content and GR and GST activities increased significantly.

Effects of DADS on NF-κB, iNOS, COX-2, and TNF-α protein expression
-------------------------------------------------------------------

The protein expression of NF-κB, iNOS, COX-2, and TNF-α is shown in [Fig. 5](#f5-bt-23-180){ref-type="fig"}. The expression levels of NF-κB, iNOS, and COX-2 in the CP group increased significantly compared with those in the control group. The TNF-α expression in the CP group was also slightly higher than that in the control group but the difference was not significant between the groups. In contrast, the expression levels of NF-κB, iNOS, and COX-2 in the CP&DADS group decreased significantly compared with those in the CP group. Although no significant difference was observed between the groups, the expression level of TNF-α in the CP&DADS group was lower than that in the CP group.

Effects of DADS on MAPKs protein expression
-------------------------------------------

The protein expression of p-JNK, p-ERK, and p-p38 is shown in [Fig. 6](#f6-bt-23-180){ref-type="fig"}. The protein expression levels of p-ERK and p-JNK in the CP group increased significantly compared with those in the control group, but only slightly increased p-p38. However, the protein expression levels of p-ERK and p-JNK in the CP&DADS group decreased significantly compared with those in the CP group.

DISCUSSION
==========

It has been reported that DADS has a number of beneficial effects against various pathological conditions caused by oxidative stress and inflammation ([@b38-bt-23-180]; [@b7-bt-23-180]; [@b24-bt-23-180]; [@b30-bt-23-180]). The results obtained in this study showed that DADS prevents CP-induced HC and that the protective effects of DADS may be due to its ability to regulate proinflammatory cytokines production by inhibition of NF-κB and MAPKs expressions, and its potent anti-oxidative capability through reduction of oxidative DNA damage in the bladder.

The side effect of HC was not directly induced by CP, but its urinary metabolite, acrolein, indeed caused the urotoxicity ([@b29-bt-23-180]). Acrolein is the most reactive of the α,β-unsaturated aldehydes and can deplete the concentration of GSH ([@b18-bt-23-180]). It has been demonstrated that CP treatment results in the production of ROS, which cause oxidative stress to urinary bladder ([@b3-bt-23-180]; [@b47-bt-23-180]; [@b24-bt-23-180]). In the present study, CP treatment produced high levels of oxidative damage, as evidenced by a significant elevation in bladder MDA concentration and a significant decrease in GSH content, as well as GR and GST activities, which suggest a role for oxidative stress in CP induced HC. However, DADS caused a significant decrease in the MDA concentration and efficiently improved the CP-induced depletion of GSH concentration and suppression of GR and GST activities in the urinary bladder. Previous studies have also demonstrated that DADS treatment results in increased GSH content and modulation of enzymic and non-enzymic antioxidant activities ([@b24-bt-23-180]; [@b30-bt-23-180]). This apparent ameliorative effect might be due to the ability of DADS to protect against LPO and oxidative stress induced by acrolein.

8-OHdG is produced by the oxidative damage of DNA by ROS and reactive nitrogen species and serves as an established marker of oxidative stress ([@b1-bt-23-180]; [@b15-bt-23-180]). Hydroxylation of guanosine occurs in response to both normal metabolic processes and a variety of environmental factors. Increased levels of 8-OHdG are associated with the aging process as well as with a number of pathological conditions including cancer, diabetes, radiation, and hypertension ([@b19-bt-23-180]; [@b15-bt-23-180]; [@b41-bt-23-180]). Moreover, urinary MDA and 8-OHdG levels indicate the extent of LPO, thereby serving as an index of oxidative stress ([@b19-bt-23-180]; [@b21-bt-23-180]). As expected, CP treatment resulted in an increase in urinary MDA and 8-OHdG levels. However, DADS prevented increase in urinary MDA and 8-OHdG levels induced by CP. These changes were accompanied by a reduction in oxidative damage in the urinary bladder.

Nitric oxide (NO) is a highly reactive free radical which has emerged as a potent biological mediator ([@b32-bt-23-180]). Increasing evidence indicates that NO is involved in acute and chronic inflammation ([@b27-bt-23-180]). NO is synthesized from L-arginine, with the formation of stoichiometric amounts of L-citrulline, by three NO synthase (NOS) isoforms: endothelial NOS, neuronal NOS, and iNOS. It is reported that cytokines and NO produced by iNOS were involved in CP-induced HC ([@b28-bt-23-180]; [@b35-bt-23-180]). NF-κB stimulates the expression of iNOS, with an increase in NO formation ([@b45-bt-23-180]). The COX-2 expression and subsequent production of prostaglandin were closely related to the generation of NO radicals ([@b36-bt-23-180]; [@b39-bt-23-180]). Therefore, agents that inhibit NF-κB, resulting in decreased iNOS and COX-2 expressions and NO generation, may have beneficial therapeutic effects in the treatment of inflammatory diseases. In this study, we hypothesized that blocking NF-κB would be an effective approach to prevent CP-induced HC. As expected, CP caused a significant increase in NF-κB, iNOS, and COX-2 expression levels and, suggesting that activation of NF-κB, iNOS, and COX-2 by CP might play a role in CP-induced HC. However, DADS pretreatment inhibited CP-induced NF-κB, iNOS, and COX-2 expressions accompanied by a reduction in urine NOx levels. These results suggest that the effects of DADS on the production of NO are at least partially mediated by suppression of NF-κB signaling. Previous studies also showed that DADS inhibited iNOS and COX-2 expressions and NO production ([@b7-bt-23-180]; [@b48-bt-23-180]).

CP is a potent activator of the MAPK pathway, which is the other major extracellular signal transduction pathway. Once activated, MAPKs modulate the functional responses of cells through phosphorylation of transcription factors and activation of other kinases ([@b49-bt-23-180]). An *in vitro* study reported that acrolein-induced Chinese hamster ovary cell apoptosis is ERK and p38 dependent ([@b46-bt-23-180]). Evidences also confirmed that CP-induced cystitis leads to ERK activation in urinary bladder ([@b9-bt-23-180]). Chung *et al*. (2010) found that nerve growth factor induced bladder inflammation and cystitis with the activation of JNK and ERK but not p38 MAPK. In the present study, CP simultaneously activated JNK and ERK but not p38 MAPK in urinary bladder. However, DADS inhibited CP-stimulated phosphorylation of ERK and JNK. A previous study reported that DADS pretreatment markedly inhibited phosphorylation of MAPKs and production of downstream proinflammatory cytokine in lipopolysaccharide (LPS)-stimulated BV2 microglia ([@b37-bt-23-180]). Therefore, these results suggest that the antiinflammatory effects were due to inhibition of the ERK and JNK signaling pathway.

Cytokines, a large group of soluble extracellular proteins or glycoproteins, are key intercellular regulators and mobilizers and they are now seen to be crucial to innate and adaptive inflammatory responses. Modulation of cytokine secretion may offer novel approaches in the treatment of a variety of diseases. One strategy in the modulation of cytokine expression may be through the use of herbal medicines ([@b43-bt-23-180]). Recent studies have demonstrated that CP-induced HC is not only due to the direct contact of acrolein with the bladder mucosa, but also involves proinflammatory cytokines such as TNF-α, IL-6, and IL-1β ([@b11-bt-23-180]; [@b16-bt-23-180]). Proinflammatory cytokines promote inflammation, leukocyte infiltration, granuloma formation, and tissue fibrosis, and are thought to be initiators of cytokine related inflammation states by stimulating cytokine production. In the present study, the elevated levels of IL-1β, IL-6, and TNF-α, the principal cytokines that mediates acute inflammation after CP administration, were effectively ameliorated by DADS, indicating their protective effect against CP-induced inflammation. A previous study showed an inhibitory effect of DADS on the production of TNF-α and IL-1β in endotoxin-stimulated whole blood culture ([@b22-bt-23-180]). Additionally, the decreased levels of TNF-α and IL-1β by DADS treatment were previously observed in LPS-activated BV2 microglia ([@b37-bt-23-180]). Recently we have also demonstrated that DADS pretreatment results in decreased IL-6 and IL-1β levels against carbon tetrachloride-induced hepatotoxicity in rats ([@b30-bt-23-180]).

In summary, our data show that DADS inhibits CP-induced urine NOx production by suppressing iNOS and COX-2 protein expressions in the urinary bladder. DADS also inhibits the production of proinflammatory cytokines by down-regulation of NF-κB and MAPKs pathways. These uroprotective effects are mediated by the antioxidative action through inhibition of LPO and increase of antioxidant enzymes activity, which is accompanied by reduction of urine MDA and 8-OHdG. Therefore, DADS could be used as an attractive and characteristic probe for studying inflammation and oxidative damage.
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![Representative photographs of bladder sections treated with CP and/or DADS. Bladder from vehicle control (A) and DADS treated (D) rats showing normal appearance. However, bladder from a CP treated rat (B) showing inflammatory cells infiltration (black arrow) and epithelial ulceration (white arrow). Bladder from a CP&DADS treated rat (C) showing mild inflammatory cells infiltration. H&E stain. Bar=40 μm.](BT-23-180f1){#f1-bt-23-180}

![Effects of DADS on CP-induced changes in serum IL-1β, IL-6, and TNF-α levels. Statistical analysis was performed using one-way ANOVA followed by the Tukey's multiple comparison test. Data are expressed as means ± SD (n=6). \**p*\<0.05 compared with the control group. \*\**p*\<0.01 compared with the control group. ^†^*p*\<0.05 compared with the CP group.](BT-23-180f2){#f2-bt-23-180}

![Effects of DADS on CP-induced changes in urine NOx (A), MDA (B), and 8-OHdG (C) levels. Statistical analysis was performed using one-way ANOVA followed by the Tukey's multiple comparison test. Data are expressed as means ± SD (n=6). \**p*\<0.05 compared with the control group. \*\**p*\<0.01 compared with the control group. ^††^*p*\<0.01 compared with the CP group.](BT-23-180f3){#f3-bt-23-180}

![Antioxidant enzymes, GSH, and LPO in the urinary bladder of male rats treated with CP and/or DADS. Statistical analysis was performed using one-way ANOVA followed by the Tukey's multiple comparison test. Data are expressed as means ± SD (n=6). \**p*\<0.05 compared with the control group. \*\**p*\<0.01 compared with the control group. ^†^*p*\<0.05 compared with the CP group. ^††^*p*\<0.01 compared with the CP group.](BT-23-180f4){#f4-bt-23-180}

![(A) Western blot analysis of NF-κB, iNOS, COX-2, and TNF-α expression in the urinary bladder of male rats treated with CP and/or DADS. Detection of β-actin expression was used a loading control. The bar graphs show quantitative relative levels of NF-κB (B), iNOS (C), COX-2 (D), and TNF-α (E) protein expression for vehicle, CP, CP&DADS, and DADS-treated rats. Values are presented as means ± SD (n=3). \*\**p*\<0.01 compared with the control group. ^††^*p*\<0.01 compared with the CP group.](BT-23-180f5){#f5-bt-23-180}

![(A) Western blot analysis of p-JNK, p-ERK, and p-p38 expression in the urinary bladder of male rats treated with CP and/or DADS. The bar graphs show quantitative relative levels of p-JNK (B), p-ERK (C), and p-p38 (D) protein expression for vehicle, CP, CP&DADS, and DADS-treated rats. Values are presented as means ± SD (n=3). \**p*\<0.05 compared with the control group. \*\**p*\<0.01 compared with the control group. ^††^*p*\<0.01 compared with the CP group.](BT-23-180f6){#f6-bt-23-180}
